Daniel Liber

Daniel Liber has a broad range of work experience in the life sciences industry. Daniel started their career in 2008 as a Research Associate at Imperial College London. In 2010, they joined Roche Diagnostics as a Technical Support Specialist - Array Systems - EMEA/LATAM. In 2011, they became an Account Manager at Diagenode, where they were responsible for doubling the turnover across their territory of competence and closing the biggest deal for epigenetic reagents in the Company history. In 2014, they moved to Illumina as a Senior Territory Account Manager and also joined GATC Biotech as a Pharmaceutical & Diagnostic Key Account Manager (Northern Europe). In 2015, they took on two roles at Takara Bio Europe as a Business Development Manager, Automation and UK-Nordics Business Development Manager - Automation. In 2021, they became a Senior Manager, Life Sciences Sales at SomaLogic. Most recently, they joined Resolve Biosciences as a Market Development Manager, UK and Nordics in 2022.

Daniel Liber obtained their PhD in Clinical Sciences from Imperial College London in 2008. Prior to that, they obtained their Laurea in Pharmaceutical Chemistry and Technology from Università degli Studi di Milano in 2004.